CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR)

Historical Holders from Q3 2024 to Q3 2025

Symbol
CTOR on Nasdaq
Type / Class
Equity / Common Shares, $0.0001 par value per share
Shares outstanding
84,787,696
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
8,357,159
Holdings value
$16,966,429
% of all portfolios
0%
Number of holders
16
Number of buys
13
Number of sells
-3
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Citius Pharmaceuticals, Inc. 78% -1.5% $79,920,034 66,049,615 0% Citius Pharmaceuticals, Inc. 10 Dec 2025
ARMISTICE CAPITAL, LLC 9.8% $15,466,961 7,675,911 Armistice Capital, LLC 30 Sep 2025

Institutional Holders of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 8,357,159 $16,966,429 +$16,255,713 $2.03 16
2025 Q2 227,492 $989,589 +$573,842 $4.35 7
2025 Q1 105,008 $97,657 -$115,521 $0.9300 6
2024 Q4 200,884 $230,275 +$180,603 $1.15 11
2024 Q3 41,238 $57,016 +$57,016 $1.39 7